MDH1B
gene geneOn this page
Also known as FLJ25341RP11-95H11
Summary
MDH1B (malate dehydrogenase 1B, HGNC:17836) is a protein-coding gene on chromosome 2q33.3, encoding Putative malate dehydrogenase 1B (Q5I0G3).
Predicted to enable L-malate dehydrogenase (NAD+) activity. Predicted to be involved in NADH metabolic process; dicarboxylic acid metabolic process; and tricarboxylic acid cycle.
Source: NCBI Gene 130752 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 88 total
- MANE Select transcript:
NM_001039845
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17836 |
| Approved symbol | MDH1B |
| Name | malate dehydrogenase 1B |
| Location | 2q33.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25341, RP11-95H11 |
| Ensembl gene | ENSG00000138400 |
| Ensembl biotype | protein_coding |
| Entrez | 130752 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron
ENST00000374412, ENST00000432911, ENST00000436472, ENST00000449792, ENST00000454776, ENST00000471988
RefSeq mRNA: 6 — MANE Select: NM_001039845
NM_001039845, NM_001282940, NM_001330223, NM_001330224, NM_001330225, NM_001330226
CCDS: CCDS33365, CCDS63102, CCDS82561
Canonical transcript exons
ENST00000374412 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001463449 | 206737763 | 206738511 |
| ENSE00001463455 | 206750934 | 206751075 |
| ENSE00001463456 | 206755009 | 206755505 |
| ENSE00001803010 | 206765250 | 206765328 |
| ENSE00003460330 | 206739593 | 206739661 |
| ENSE00003466545 | 206757237 | 206757371 |
| ENSE00003559813 | 206746287 | 206746426 |
| ENSE00003564194 | 206760901 | 206761013 |
| ENSE00003567346 | 206749020 | 206749183 |
| ENSE00003567562 | 206756898 | 206757040 |
| ENSE00003574442 | 206745622 | 206745673 |
| ENSE00003687005 | 206741054 | 206741104 |
Expression profiles
Bgee: expression breadth ubiquitous, 182 present calls, max score 97.72.
FANTOM5 (CAGE): breadth broad, TPM avg 1.6786 / max 67.9668, expressed in 684 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 33362 | 1.0693 | 509 |
| 33363 | 0.6093 | 265 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 97.72 | gold quality |
| right uterine tube | UBERON:0001302 | 96.81 | gold quality |
| bronchus | UBERON:0002185 | 96.34 | gold quality |
| oviduct epithelium | UBERON:0004804 | 95.65 | gold quality |
| sperm | CL:0000019 | 91.78 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 88.57 | gold quality |
| left testis | UBERON:0004533 | 87.45 | gold quality |
| right testis | UBERON:0004534 | 86.50 | gold quality |
| testis | UBERON:0000473 | 86.35 | gold quality |
| fallopian tube | UBERON:0003889 | 86.05 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 85.81 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.48 | gold quality |
| pituitary gland | UBERON:0000007 | 83.86 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 83.33 | gold quality |
| adenohypophysis | UBERON:0002196 | 83.06 | gold quality |
| adult organism | UBERON:0007023 | 83.06 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.45 | gold quality |
| pancreatic ductal cell | CL:0002079 | 79.40 | silver quality |
| left lobe of thyroid gland | UBERON:0001120 | 78.10 | gold quality |
| thyroid gland | UBERON:0002046 | 77.63 | gold quality |
| metanephros cortex | UBERON:0010533 | 77.55 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 77.27 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 77.22 | gold quality |
| caput epididymis | UBERON:0004358 | 74.10 | gold quality |
| caudate nucleus | UBERON:0001873 | 73.86 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 73.18 | silver quality |
| nucleus accumbens | UBERON:0001882 | 72.76 | gold quality |
| prefrontal cortex | UBERON:0000451 | 72.61 | gold quality |
| ventricular zone | UBERON:0003053 | 72.34 | gold quality |
| metanephros | UBERON:0000081 | 72.30 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.68 |
| E-GEOD-124858 | no | 52.40 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
57 targeting MDH1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-26A-5P | 99.78 | 73.52 | 2303 |
| HSA-MIR-26B-5P | 99.78 | 73.51 | 2305 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-4465 | 99.71 | 72.56 | 2096 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-6715B-5P | 99.64 | 69.63 | 1420 |
| HSA-MIR-12122 | 99.56 | 69.33 | 1672 |
| HSA-MIR-4269 | 99.55 | 69.89 | 1373 |
| HSA-MIR-549A-3P | 99.54 | 68.17 | 825 |
| HSA-MIR-888-3P | 99.53 | 69.77 | 1057 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mdh1b | ENSDARG00000018008 |
| mus_musculus | Mdh1b | ENSMUSG00000025963 |
| rattus_norvegicus | Mdh1b | ENSRNOG00000012891 |
| drosophila_melanogaster | Mdh1 | FBGN0262782 |
| caenorhabditis_elegans | WBGENE00018491 |
Paralogs (1): MDH1 (ENSG00000014641)
Protein
Protein identifiers
Putative malate dehydrogenase 1B — Q5I0G3 (reviewed: Q5I0G3)
All UniProt accessions (3): B4DY40, C9JER5, Q5I0G3
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the LDH/MDH superfamily. MDH type 2 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5I0G3-1 | 1 | yes |
| Q5I0G3-2 | 2 | |
| Q5I0G3-3 | 3 |
RefSeq proteins (6): NP_001034934, NP_001269869, NP_001317152, NP_001317153, NP_001317154, NP_001317155 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010945 | Malate_DH_type2 | Family |
| IPR015955 | Lactate_DH/Glyco_Ohase_4_C | Homologous_superfamily |
| IPR022383 | Lactate/malate_DH_C | Domain |
| IPR036291 | NAD(P)-bd_dom_sf | Homologous_superfamily |
Pfam: PF02866
UniProt features (8 total): splice variant 3, sequence variant 3, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5I0G3-F1 | 86.46 | 0.71 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 81 (showing top):
GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN, GOBP_OXALOACETATE_METABOLIC_PROCESS, GOBP_NADPLUS_METABOLIC_PROCESS, GOBP_DICARBOXYLIC_ACID_METABOLIC_PROCESS, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS, GOBP_CELLULAR_RESPIRATION, GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, RFX1_01, DODD_NASOPHARYNGEAL_CARCINOMA_DN
GO Biological Process (4): tricarboxylic acid cycle (GO:0006099), oxaloacetate metabolic process (GO:0006107), malate metabolic process (GO:0006108), obsolete NADH metabolic process (GO:0006734)
GO Molecular Function (5): L-malate dehydrogenase (NAD+) activity (GO:0030060), catalytic activity (GO:0003824), oxidoreductase activity (GO:0016491), malate dehydrogenase activity (GO:0016615), oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| dicarboxylic acid metabolic process | 2 |
| oxidoreductase activity, acting on CH-OH group of donors | 2 |
| aerobic respiration | 1 |
| primary metabolic process | 1 |
| malate dehydrogenase activity | 1 |
| oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1 |
| molecular_function | 1 |
| catalytic activity | 1 |
Protein interactions and networks
STRING
3115 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MDH1B | TTC16 | Q8NEE8 | 574 |
| MDH1B | OGDH | Q02218 | 533 |
| MDH1B | PKLR | P11973 | 512 |
| MDH1B | OGDHL | Q9ULD0 | 502 |
| MDH1B | FBP1 | P09467 | 487 |
| MDH1B | ACO2 | Q99798 | 481 |
| MDH1B | RBKS | Q9H477 | 481 |
| MDH1B | PGAM2 | P15259 | 478 |
| MDH1B | PDHB | P11177 | 476 |
| MDH1B | IDH3A | P50213 | 472 |
| MDH1B | MDH2 | P40926 | 472 |
| MDH1B | IDH2 | P48735 | 472 |
| MDH1B | ACO1 | P21399 | 471 |
| MDH1B | DLD | P09622 | 467 |
| MDH1B | FH | P07954 | 462 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EPHA3 | FHAD1 | psi-mi:“MI:0914”(association) | 0.350 |
| STYK1 | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): MDH1B (Affinity Capture-MS), MDH1B (Affinity Capture-MS)
ESM2 similar proteins: A1KXW8, A6QL50, E1BGQ2, H0Y354, O94955, P47224, Q08326, Q0IIH8, Q1JQA1, Q1RMS8, Q1RMZ1, Q2TBU5, Q3T1H6, Q4R372, Q4R528, Q4R9C4, Q5F480, Q5F4A1, Q5I0G3, Q5RCQ0, Q5RFG8, Q5TFE4, Q5TYM5, Q641X7, Q6L9T8, Q6PIP5, Q7L622, Q7Z6J8, Q7ZX59, Q86X60, Q8BFZ8, Q8BKW4, Q8BM85, Q8BX13, Q8CEL2, Q8N5C7, Q8N635, Q8NHU2, Q8TCF1, Q8TCJ0
Diamond homologs: A3KMX7, Q08BZ4, Q5F204, Q5I0G3, Q8T773, A1W9K7, A4FFX3, A5IEF4, B0SF41, B0SN74, B9MBP0, C1B155, P15719, P37229, Q0S365, Q1AWH4, Q47TT4, Q5WU94, Q5X2T6, Q5ZT13, Q82HS2, Q8PNP8, Q9RXI8, F1C7I4, A0PVV1, A0QCI6, B2HRH5, B2UKY5, O24047, O48902, O48905, O88989, P11708, P21528, P40925, P57106, P61976, P93819, Q08062, Q0RE66
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
88 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 75 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2013 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:206749180:CTCA:C | acceptor_gain | 1.0000 |
| 2:206757227:A:C | donor_gain | 1.0000 |
| 2:206739662:C:CC | acceptor_gain | 0.9900 |
| 2:206741053:CCAT:C | donor_gain | 0.9900 |
| 2:206746280:ACATT:A | donor_loss | 0.9900 |
| 2:206746281:CATTA:C | donor_loss | 0.9900 |
| 2:206746282:ATTAC:A | donor_loss | 0.9900 |
| 2:206746283:TTA:T | donor_loss | 0.9900 |
| 2:206746284:TACCT:T | donor_loss | 0.9900 |
| 2:206746285:A:G | donor_loss | 0.9900 |
| 2:206746286:C:CA | donor_loss | 0.9900 |
| 2:206746287:C:G | donor_loss | 0.9900 |
| 2:206746422:CTGGC:C | acceptor_gain | 0.9900 |
| 2:206746423:TGGCC:T | acceptor_loss | 0.9900 |
| 2:206746424:GGCCT:G | acceptor_loss | 0.9900 |
| 2:206746425:GCCTG:G | acceptor_loss | 0.9900 |
| 2:206746426:CCTGC:C | acceptor_loss | 0.9900 |
| 2:206746427:C:CC | acceptor_gain | 0.9900 |
| 2:206746427:CTGC:C | acceptor_loss | 0.9900 |
| 2:206746428:T:A | acceptor_loss | 0.9900 |
| 2:206749182:CA:C | acceptor_gain | 0.9900 |
| 2:206749184:C:CC | acceptor_gain | 0.9900 |
| 2:206755007:A:AC | donor_gain | 0.9900 |
| 2:206755008:C:CC | donor_gain | 0.9900 |
| 2:206755257:T:TA | donor_gain | 0.9900 |
| 2:206755504:CA:C | acceptor_gain | 0.9900 |
| 2:206755506:C:CC | acceptor_gain | 0.9900 |
| 2:206756946:T:TA | donor_gain | 0.9900 |
| 2:206757036:TAAAG:T | acceptor_gain | 0.9900 |
| 2:206757041:C:CC | acceptor_gain | 0.9900 |
AlphaMissense
3415 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:206751055:A:G | W311R | 0.985 |
| 2:206751055:A:T | W311R | 0.985 |
| 2:206751051:C:A | G312V | 0.983 |
| 2:206765250:C:G | G8R | 0.983 |
| 2:206755133:G:C | N262K | 0.982 |
| 2:206755133:G:T | N262K | 0.982 |
| 2:206757253:A:G | F85S | 0.981 |
| 2:206757311:A:G | W66R | 0.981 |
| 2:206757311:A:T | W66R | 0.981 |
| 2:206757252:G:C | F85L | 0.977 |
| 2:206757252:G:T | F85L | 0.977 |
| 2:206757254:A:G | F85L | 0.977 |
| 2:206760962:A:G | L25S | 0.977 |
| 2:206749024:A:C | S404R | 0.976 |
| 2:206749024:A:T | S404R | 0.976 |
| 2:206749026:T:G | S404R | 0.976 |
| 2:206751052:C:G | G312R | 0.976 |
| 2:206755035:G:T | A295D | 0.976 |
| 2:206755036:C:G | A295P | 0.975 |
| 2:206757338:A:G | W57R | 0.974 |
| 2:206757338:A:T | W57R | 0.974 |
| 2:206760972:C:G | A22P | 0.974 |
| 2:206760940:A:C | F32L | 0.972 |
| 2:206760940:A:T | F32L | 0.972 |
| 2:206760942:A:G | F32L | 0.972 |
| 2:206749082:A:G | L385P | 0.971 |
| 2:206755479:A:G | L147P | 0.971 |
| 2:206749074:A:G | W388R | 0.969 |
| 2:206749074:A:T | W388R | 0.969 |
| 2:206757242:C:G | A89P | 0.968 |
dbSNP variants (sampled 300 via entrez): RS1000004909 (2:206744510 C>T), RS1000290596 (2:206745278 T>C), RS1000365316 (2:206751510 A>G), RS1000369963 (2:206758964 T>G), RS1000372909 (2:206758148 A>G), RS1000390414 (2:206757968 A>C), RS1000396391 (2:206751793 T>G), RS1000593048 (2:206739028 G>A), RS1000644193 (2:206745733 T>A,C), RS1000704384 (2:206757441 T>C,G), RS1000732735 (2:206750247 T>C), RS1000762814 (2:206757685 G>C), RS1001102986 (2:206750064 T>C), RS1001213818 (2:206764238 C>T), RS1001382041 (2:206738265 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_45 | Body mass index | 1.000000e-09 |
| GCST009391_420 | Metabolite levels | 3.000000e-06 |
| GCST009391_906 | Metabolite levels | 9.000000e-07 |
| GCST009391_923 | Metabolite levels | 3.000000e-06 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0010388 | phosphatidylcholine 38:6 measurement |
| EFO:0010442 | triacylglycerol 58:8 measurement |
| EFO:0010443 | triacylglycerol 58:9 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 4 |
| Gold | decreases expression, affects binding | 2 |
| methylmercuric chloride | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| abrine | decreases expression | 1 |
| jinfukang | increases expression, affects cotreatment | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Polyethyleneimine | affects binding, decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.